EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comparison of Ex-House and In-House Cytology for the New Cervical Cancer Screening Assessment

Lena Sophia Nieberle iD, Anna Katharina Dietl, Anja Seibold, Lena Brückner, Oliver Schleicher, Carla Schulmeyer, Julius Emons, Annika Sophie Behrens, Sebastian Trnovec, Arndt Hartmann, Matthias W Beckmann, Antje Knöll und 4 weitere

Geburtshilfe und Frauenheilkunde · 01.08.2026 · 86 (08) · 766-776

DOI: 10.1055/a-2900-6511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Geburtshilfe und Frauenheilkunde, erschienen am 01.08.2026. Verfasst von Lena Sophia Nieberle und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and ObstetricsComprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN)Erlangen University H…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The introduction of an organized cervical cancer screening program in Germany in 2020 changed screening algorithms and referral patterns, increasing the number of patients referred to specialized centers. This study examines the concordance between ex-house Pap smear findings and in-house colposcopy-guided cytology and relates both to colposcopy-guided biopsy and histopathological outcomes within the new screening program. In this retrospective study, data from 3161 patients referred for colposcopy to a certified university dysplasia unit between January 2020 and May 2024 were analyzed. All patients underwent standardized assessment including Pap smear, HPV testing, colposcopy, and colposcopy-guided biopsy, with surgical treatment when indicated. Concordance between ex-house and in-house cytology was moderate (Spearman’s ρ = 0.453, p < 0.001; weighted Cohen’s κ = 0.581). Compared with histology, ex-house cytology showed overdiagnosis in 252 cases (14.29%), underdiagnosis in 631 cases (35.79%), and concordant findings in 880 cases (49.91%). In contrast, in-house cytology demonstrated lower rates of overdiagnosis (183 cases, 9.48%) and underdiagnosis (495 cases, 25.65%), with agreement in 1252 cases (64.87%). HPV positivity increased with cytological severity, with HPV16 being the most prevalent genotype in high-grade lesions. Among low-grade cytological findings, CIN3+ yield differed markedly according to HPV status. In the setting of the cervical cancer screening program, in-house cytology performed in a specialized dysplasia unit demonstrated closer agreement with histology than ex-house cytology. HPV status emerged as a key modifier of risk within low-grade cytological categories, highlighting the importance of risk-adapted triage and reassessment colposcopy in contemporary screening practice.

Schlagwörter

Stichwörter der Autor:innen

cervical cancercervical intraepithelial neoplasia (CIN)colposcopydysplasiahigh-grade squamous intraepithelial lesion (HSIL)low-grade squamous intraepithelial lesion (LSIL)

Autor:innen und Institutionen

  • Department of Gynecology and ObstetricsComprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN)Erlangen University Hospital, Friedrich-Alexander-Universität Erlangen-NürnbergErlangenGerm…
  • Bavarian Cancer Research Center (BZFK)ErlangenGermany.
  • Institute of PathologyComprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN)Erlangen University Hospital, Friedrich-Alexander-Universität Erlangen-NürnbergErlangenGermany.
  • Harald zur Hausen Institute of VirologyErlangen University Hospital, Friedrich-Alexander-Universität Erlangen-NürnbergErlangenGermany.
  • Gynecology Consultancy Practice, German Cancer Society [DKG]and Committee on Cervical Pathology and Colposcopy [AG-CPC] Certified Gynaecological Dysplasia Consultancy PracticeFrauenarztpraxis ErlangenErlangenGermany.
  • Department of Medical Informatics, Biometry and EpidemiologyFriedrich-Alexander-Universität Erlangen-NürnbergErlangenGermany.

ORCID-Profile: Lena Sophia Nieberle, Frederik Alexander Stübs

Zitieren

APA

Nieberle, L. S., Dietl, A. K., Seibold, A., Brückner, L., Schleicher, O., Schulmeyer, C., Emons, J., Behrens, A. S., Trnovec, S., Hartmann, A., Beckmann, M. W., Knöll, A., Mehlhorn, G., Adler, W., Geppert, C., & Stübs, F. A. (2026). Comparison of Ex-House and In-House Cytology for the New Cervical Cancer Screening Assessment. Geburtshilfe und Frauenheilkunde, 86(08), 766-776. https://doi.org/10.1055/a-2900-6511

Vancouver

Nieberle LS, Dietl AK, Seibold A, Brückner L, Schleicher O, Schulmeyer C, et al. Comparison of Ex-House and In-House Cytology for the New Cervical Cancer Screening Assessment. Geburtshilfe und Frauenheilkunde. 2026;86(08):766-776. doi:10.1055/a-2900-6511

BibTeX
@article{Nieberle2026,
  author = {Nieberle, Lena Sophia and Dietl, Anna Katharina and Seibold, Anja and Brückner, Lena and Schleicher, Oliver and Schulmeyer, Carla and Emons, Julius and Behrens, Annika Sophie and Trnovec, Sebastian and Hartmann, Arndt and Beckmann, Matthias W and Knöll, Antje and Mehlhorn, Grit and Adler, Werner and Geppert, Carol and Stübs, Frederik Alexander},
  title = {Comparison of Ex-House and In-House Cytology for the New Cervical Cancer Screening Assessment},
  journal = {Geburtshilfe und Frauenheilkunde},
  year = {2026},
  volume = {86},
  number = {08},
  pages = {766--776},
  doi = {10.1055/a-2900-6511}
}
Kostenlos starten →